Glucomannan: Properties and therapeutic applications;Glucomanano: Propiedades y aplicaciones terapéuticas

Nutricion Hospitalaria

Volumn 19, Issue 1, 2004, Pages 45-50

  Gonzalez Canga A ^a   Fernandez Martinez N ^a   Sahagun A Ma ^a   Garcia Vieitez J J ^a   Diez Liebana Ma J ^a   Calle Pardo, A P ^a   Castro Robles, L J ^a   Sierra Vega, M ^a  

^a UNIVERSITY OF LEÓN   (Spain)

Author keywords

Dietary fiber; Glucomannan

Indexed keywords

MANNAN; (1 6) ALPHA GLUCOMANNAN; (1-6)-ALPHA-GLUCOMANNAN;

ANALYTIC METHOD; CHEMICAL STRUCTURE; DIET; NUTRITIONAL ASSESSMENT; PHYSICAL CHEMISTRY; REVIEW; STRUCTURE ANALYSIS; THERAPY EFFECT; ANIMAL; DIETARY FIBER; HUMAN;

AMORPHOPHALLUS KONJAC; ARACEAE;

ANIMALS; DIETARY FIBER; HUMANS; MANNANS;

EID: 2142699372     PISSN: 02121611     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Sugiyama N, Shimahara H y Andoh T: Studies on mannan and related compounds: the purification of konjac mannan. Bull Chem Soc Jpn, 1972, 45:561-563.
2. Kiriyama S, Enishi A y Yura K: Inhibitory effect of KGM on bile acid transport in the everted sacs from rat illeum. J Nutr, 1974, 104:69-78.
3. Vorster HH, Kruger HS, Frylink S, Botha BJ, Lombaard WA y De Jager J: Physiological effects of the dietary fibre component konjac glucomannan in rats and baboons. J Plant Foods, 1985, 6:263-274.
4. Nishinari K, Williams PA y Phillips GO: Review of the physico-chemical characteristics and properties of konjac mannan. Food Hydrocol, 1992; 6:199-222.
5. Kato K y Matsuda K: Studies on the chemical stucture of konjac mannan. Part I. Isolation and characterization of oligosaccharides from the partial acid hydrolyzate of mannan. Agric Biol Chem, 1969, 33:1446-1453.
6. Kato K, Watanabe T y Matsuda K: Studies on the chemical structure of konjac mannan. Part II. Isolation and characterization of oligosaccharides from the partial acid hydrolyzate of mannan. Agric Biol Chem, 1970a, 34:532-539.
7. Kato K, Watanabe T y Matsuda K: Studies on the chemical structure of konjac mannan. Part III. Theorical aspect of controlled degradation of the main chain of the mannan. Agric Biol Chem, 1970b, 36:639-644.
8. Shimahara H, Suzuki H, Sugiyama N y Nishizawa K: Isolation and characterization of oligosaccharides from a enzymic hydrolisate of konjac glucomannan. Agric Biol Chem, 1975a, 39:293-299.
9. Shimahara H, Suzuki H, Sugiyama N y Nishizawa K: Partial purification of β-mannanase from the tubers and their substrate specificity in relation to the structure of konjac glucomannan. Agric Biol Chem, 1975b, 39:301-312.
10. Maeda M, Shimahara H y Sugiyama N: Detailed examination of the branched structure of konjac glucomannan. Agric Biol Chem, 1980, 44:245-252.
11. Yui T, Ogawa K y Sarko A: Molecular and crystal structure of konjac glucomannan in the mannan II polymorphic form. Carbohydr Res, 1992, 229:41-55.
12. Williams MAK, Foster TJ, Martin DR, Norton IT, Yoshimura M y Nishinari K: A molecular description of the gelation mechanism of konjac mannan. Biomacromol, 2000; 1:440-450.
13. Maekaji K: The mechanism of gelation of konjac mannan. Agric Biol Chem, 1974, 38:315-321.
14. Kishida N, Okimasu S y Kamata T: Molecular weight and intrinsic viscosity of konjac glucomannan. Agric Biol Chem, 1978, 42:1465-1470.
15. Fanelli V, Angelico F, Stefanutti C, Calvieri A y Fazio S: Effetti della integrazione della dieta abituale con le fibre di glucomannano nell'ipercolesterolemia. Clin Ter, 1986, 119:17-23.
16. Rosado JL y Díaz M: Propiedades fisicoquímicas relacionadas con función gastrointestinal de seis fuentes de fibra dietética. Rev Invest Clin, 1995, 47:283-289.
17. Kiriyama S, Enishi A, Yoshida A, Suhiyama N y Shimahara H: Hypocholesterolemic activity and molecular weight of konjac mannan. Nutr Rep Int, 1972, 6:231-236.
18. Walsh DE, Yaghoubian V y Behforooz A: Effect of glucomannan on obese patients: a clinical study. Int J Obes, 1984, 8:289-293.
19. Biancardi G, Palmiero L y Ghirardi PE: Glucomannan in the treatment of overweight patients with osteoartrosis. Curr Ther Res, 1989, 46:908-912.
20. Vita PM, Restelli A, Caspani P y Klinger R: Chronic use of glucomannan in the dietary treatment of severe obesity. Minerva Med, 1992, 83:135-139.
21. Cairella M y Marchini G: Evaluation of the action of glucomannan on metabolic parameteres and on the sensation of satiation in overweight and obese patients. Clin Ter, 1995, 146:269-274.
22. Marzio L, Del Bianco R, Donne MD, Pieramico O y Cuccurullo F: Mouth to cecum transit time in patients affected by chronic constipation: effect of glucomannan. Am J Gastroenterol, 1989, 84:888-891.
23. Passaretti S, Franzoni M, Comin U y cols.: Action of glucomannans on complaints in patients affected with chronic constipation: a multicentric clinical evaluation. Ital J Gastroenterol, 1991, 23:421-425.
24. Marsicano LJ, Berrizbeitia ML y Mondelo A: Use of glucomannan dietary fiber in changes in intestinal habit. GEN, 1995, 49:7-14.
25. Signorelli P, Croce P y Dedè A: Studio clinico dell'impiego di una associazione di glucomannano con lattulosio nella stipsi gravidica. Minerva Ginecol, 1996, 48:577-582.
26. Staiano A, Simeone D, Del Guiudice E, Miele E, Tozzi A y Toraldo C: Effect of the dietary fiber glucomannan on chronic constipation in neurologycally impaired children. J Pediatr, 2000, 136:41-45.
27. Mitsuoka T: The effect of nutrition on intestinal flora. Nahrung, 1984, 28:619-625.
28. Fujiwara S, Hirota T, Nakazato H, Mizutani T y Mitsuoka T: Effect of konjac mannan on intestinal microbial metabolism in mice wearing human flora and in conventional F344 rats. Food Chem Toxicol, 1991, 29:601-616.
29. Matsuura Y: Degradation of konjak glucomannan by enzymes in human feces and formation of short-chain fatty acids by intestinal anaerobic bacteria. J Nutr Sci Vitaminol, 1998, 44:423-436.
30. Oku T y Kwon S: Disaccharidase activity in rat cecum and colon with hyperplasia induced by maltitol or glucomannan. J Nutr Sci Vitaminol, 1998, 44:69-78.
31. Doi K, Matsuura M, Kawara A y Baba S: Treatment of diabetes with glucomannan (konjac mannan). Lancet, 1979, 1:987-988.
32. Doi K, Matsuura M, Kawara A, Uenoyama R y Baba S: Effect of glucomannan (konjac fiber) on glucose and lipid metabolism in normal and diabetic subjects. En: Melish SJ, Hanna J, Baba S (eds.): Genetic environmental interaction in diabetes mellitus. Amsterdam: Excerpta Medica, 1981: 306-312.
33. Magnati G, Arsenio L, Bodria P, Lateana M y Strata A: Fibre dietetiche ed OGTT: variazioni glicemiche dopo somministrazione di un nuovo glucomannano purificato. Acta Biomed Ateneo Parmense, 1984, 55:5-14.
34. Melga P, Giusto M, Ciuchi E, Giusti R y Prando R: Le fibre alimentari nella terapia dietetica del diabete mellito: dati sperimentali con glucomanani purificati. Eur Rev Med Pharmacol Sci, 1992, 14:367-373.
35. Vuksan V, Jenkins DJ, Spadafora P y cols.: Konjac mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. Diabetes Care, 1999, 22:913-919.
36. Vorster HH y De Jager J: The effect of the long-term ingestion of konjac glucomannan on glucose tolerance and inmunoreactive insulin values of baboons. S Afr Med J, 1984, 65:805-808.
37. Venter CS, Vorster HH y Van Der Nest DG: Comparison between physiological effects of konjac-glucomannan and propionate in baboons fed western diets. J Nutr, 1990, 120:1046-1053.
38. Doi K y Baba S: Diabetes and dietary fiber. J Clin Nutr, 1981, 59:567-573.
39. Ebihara K, Masuhara R y Kiriyama S: Major determinants: plasma glucose flattening activity of a water soluble dietary fiber: effects of konjac mannan on gastric emptying and intraluminal glucose diffusion. Nutr Rep Intl, 1981, 23:1145-1156.
40. Hopman WP, Houben PG, Speth PA y Lamers CB: Glucomannan prevents postprandial hypoglycaemia in patients with previous gastric surgery. Gut, 1988, 29:930-934.
41. Kneepkens CM, Fernandes J y Vonk RJ: Dumping syndrome in children: diagnosis and effect of glucomannan on glucose tolerance and absorption. Acta Paediatr Scand, 1988, 77:279-286.
42. Venter CS, Kruger HS, Vorster HH, Serfonrein WJ, Ubbinik JB y DeVilliers LS: The effects of dietary fiber component konjac-glucomannan on serum cholesterol levels of hypercholesterolemic subjects. Hum Nutr, 1987, 41:55-61.
43. Reffo GC, Ghirardi PE y Foratini C: Glucomannan in hypertensive outpatients: pilot clinical trial. Curr Ther Res, 1988, 44:22-27.
44. Livieri C, Novazi F y Lorini R: Impiego di fibre a base di glucomannano altamente purificato nell'obesitá infantile. Ped Med Chir, 1992, 14:195-198.
45. Arvill A y Bodin L: Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men. Am J Clin Nutr, 1995, 61:585-589.
46. Hou YH, Zhang LS, Zhou HM, Wang RS y Zhang YZ: Influence of refined konjac meal on the levels of tissue lipids and the absorption of four minerals in rats. Biomed Environ Sci, 1990, 3:306-314.
47. Venter CS, Nel CJ, Vorster HH y cols.: Soluble fibre concentrate lowers plasminogen activator inhibitor-1 in baboons. Brit J Nutr, 1997, 78:625-637.
48. Kiriyama S, Morisaki H y Yoshida A: Changes in hypocholesterolemic activity in rats by various konnyaku powder treatments. Agric Biol Chem, 1970, 34:641-643.
49. Shimizu H, Yamauchi M, Kuramoto T, Kubota N, Matsuda M y Hoshita T: Effects of dietary konjac mannan on serum and liver cholesterol levels and biliary bile acid composition in hamsters. J Pharmacobiodyn, 1991, 14:371-375.
50. Wu J y Peng SS: Comparison of hypolipidemic effect of refined konjac meal with several common dietary fibers and their mechanisms of action. Biomed Environ Sci, 1997, 10:27-37.
51. Gallaher CM, Munion J, Hesslink R Jr, Wise J y Gallaher DD: Cholesterol reduction by glucomannan and chitosan is mediated by changes in cholesterol absorption and bile acid and fat excretion in rats. J Nutr, 2000, 130:2753-2759.
52. Levrat-Verny MA, Behr S, Mustad V, Rémesy C y Demiqné C: Low levels of viscous hydrocolloids lower plasma cholesterol in rats primarily by impairing cholesterol absorption. J Nutr, 2000, 130:243-248.
53. 12 and vitamin E. Tohoku J Exp Med, 1983, 141:677-681.
54. Yoshida M, Sawa J, Hozumi T y cols.: Effects of long-term high-fiber diet on macrovascular changes and lipid and glucose levels in STZ-induced diabetic rats. Diab Res Clin Pract, 1991, 13:147-152.
55. Hozumi T, Yoshida M, Ishida Y y cols.: Long-term effects of dietary fiber supplementation on serum glucose and lipoprotein levels in diabetic rats fed a high cholesterol diet. Endocr J, 1995, 42:187-192.
56. Zhang MY, Peng SS, Zhang YZ y Wu ZH: Long-term feeding trial of the refined konjac meal: effects of the refined konjac meal on the calcium and phosphorus metabolism and the bone in rat. Biomed Environ Sci, 1995, 8:74-79.
57. Gaudry P: Glucomannan diet tablets. Med J Aust, 1985, 142:204.
58. Henry DA, Mitchell A, Aylward J, Fung M, McEwen J y Roah A: Glucomannan and risk of oesophageal obstruction. Br Med J, 1986, 292:591-592.
59. Shima K, Tanaka A, Ikegami H, Tabata M, Sawazaki N y Kumahara Y: Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man. Horm Metab Res, 1983, 15:1-3.